Floris Koumans, the founder and former majority owner of BioClin commented, "BioClin has grown tremendously and become the largest company in my group of companies. I'm excited we decided to partner with Trimb as they share a mindset like ours. They have a strong ambition, and the infrastructure and resources to continue to build our products around the world."
Magnus Nylén, CEO of Trimb said, "we have followed BioClin's success for a number of years, and I'm honored to welcome BioClin's employees and products to Trimb, as we continue to build Trimb into one of the leading healthcare companies in Europe. BioClin has great product development capabilities. This acquisition further establishes our position within intimate health, while simultaneously strengthening our position in key markets."
For more information, please contact:
Magnus Nylén, CEO Trimb
Anders Larnholt, VP M&A Trimb
About Trimb Healthcare AB
Trimb is a rapidly-growing OTC and consumer healthcare company based in Stockholm, Sweden. The company's experience and competencies span across all regulatory classes and most therapy fields relevant to consumer healthcare. Trimb's products are sold in more than 60 countries and the company has its own go-to-market organization in northern Europe. (www.trimb.com)
This information was brought to you by Cision http://news.cision.com
The following files are available for download:
209 - 215 Blackfriars Road
LONDON United Kingdom